KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$33.6 million.

  • BioNTech SE's Income towards Parent Company fell 11542.21% to -$33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$730.0 million, marking a year-over-year decrease of 69181.54%. This contributed to the annual value of -$710.9 million for FY2024, which is 14582.55% down from last year.
  • BioNTech SE's Income towards Parent Company amounted to -$33.6 million in Q3 2025, which was down 11542.21% from -$474.1 million recorded in Q2 2025.
  • BioNTech SE's Income towards Parent Company's 5-year high stood at $7.2 billion during Q3 2021, with a 5-year trough of -$865.6 million in Q2 2024.
  • Over the past 5 years, BioNTech SE's median Income towards Parent Company value was $277.3 million (recorded in 2024), while the average stood at $1.5 billion.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first surged by 6418573663.12% in 2022, then crashed by 31749.74% in 2024.
  • BioNTech SE's Income towards Parent Company (Quarter) stood at $3622.0 in 2021, then skyrocketed by 64185736.63% to $2.3 billion in 2022, then tumbled by 59.81% to $934.5 million in 2023, then crashed by 70.32% to $277.3 million in 2024, then plummeted by 112.1% to -$33.6 million in 2025.
  • Its last three reported values are -$33.6 million in Q3 2025, -$474.1 million for Q2 2025, and -$499.6 million during Q1 2025.